Propranolol as a potentially novel treatment of arteriovenous malformations
Open Access
- 3 April 2018
- journal article
- case report
- Published by Elsevier BV in JAAD Case Reports
- Vol. 4 (4), 355-358
- https://doi.org/10.1016/j.jdcr.2017.11.005
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Efficacy and safety of embolization in arteriovenous malformations of the extremities and head and neck: a retrospective study of 32 casesEuropean Journal Of Dermatology, 2015
- Sustained activation of c-Jun N-terminal and extracellular signal-regulated kinases in port-wine stain blood vesselsJournal of the American Academy of Dermatology, 2014
- Successful treatment of a congenital extra-truncal vascular malformation by orally administered propranololJournal of Dermatological Treatment, 2013
- Consensus Document of the International Union of Angiology (IUA)-2013. Current concept on the management of arterio-venous management.2013
- Congenital Subclavian Arteriovenous Malformation Causing Cardiac Failure in an AdultJournal of the American Society of Echocardiography, 2009
- Management of arteriovenous malformations: a multidisciplinary approachJournal of Vascular Surgery, 2004
- Identification of an angiogenic factor that when mutated causes susceptibility to Klippel–Trenaunay syndromeNature, 2004
- Capillary Malformation–Arteriovenous Malformation, a New Clinical and Genetic Disorder Caused by RASA1 MutationsAmerican Journal of Human Genetics, 2003